Navigation Links
American Diabetes Month(R) Brings Awareness to Growing Health Care Crisis
Date:10/30/2007

According to American Diabetes Association, 1 in 4 Americans has diabetes or is at risk for developing type 2 diabetes

ALEXANDRIA, Va., Oct. 30 /PRNewswire-USNewswire/ -- The following release was issued today by the American Diabetes Association:

WHAT:

The American Diabetes Association's (ADA) American Diabetes Month(R) brings to light the fastest growing health care crisis of the 21st century: diabetes. Nearly 75 million Americans have diabetes or are at risk of developing type 2 diabetes.

HOW:

Every week in November, the ADA will highlight the "Many Faces of

Diabetes."

-- Week 1 - Caregivers: Supporting a loved one with diabetes can present

its own unique challenges.

-- Week 2 - Employees: Promoting healthy lifestyles in the workplace can

help to prevent type 2 diabetes and its complications, saving

companies thousands of dollars a year.

-- Week 3 - Diabetes around the world: Worldwide over 246 million people

have diabetes. By 2020, that number is expected to rise to 380

million. The ADA is a proud supporter of World Diabetes Day (November

14) and the United Nations Resolution on Diabetes. The Resolution

invites supporters to fight the diabetes epidemic through public

awareness and the development of policies for the prevention,

treatment, and care of the disease.

-- Week 4 - At-risk populations: One in two minorities born in 2000 will

develop diabetes in their lifetime if current trends continue.

-- Week 5 - Youth and Type 1 Diabetes: Youth diagnosed with type 1

diabetes have the most urgent need for care. The new ADA Planet D

campaign will provide resources and networking to those youth and

their families.

WHO:

The American Diabetes Association is the leading non-profit health organization dedicated to preventing and curing diabetes and to improving the
'/>"/>

SOURCE American Diabetes Association
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Abstain from sex- the latest mantra of American teens
2. Clintons new problem - Is the outgoing American president suffering from skin cancer?
3. American scientists alter gene makeup of babies
4. FDA attacks American Red Cross for blood violations
5. Poll Finds Many Americans Misinformed About Cancer
6. Poll Finds Many Americans Misinformed About Cancer
7. Hypertension Drug of Choice for African Americans
8. 38 million Americans including 14 million children left to combat hunger
9. Americans Consume Far Too Much Salt and Sodium
10. Americans Growing Out Of Shape
11. Rise in Stress among Americans
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 2Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 3FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 2FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 3FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 4New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals 2New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals 3New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals 4VisEn Launches New OsteoSense 28R 29 800 and VivoTag 28R 29 800 Fluorescence Molecular Imaging Agents 6408 1VisEn Launches New OsteoSense 28R 29 800 and VivoTag 28R 29 800 Fluorescence Molecular Imaging Agents 6408 2VerifyNow 28R 29 System Highlighted in POPular Study Comparing Platelet Reactivity Tests 6404 1VerifyNow 28R 29 System Highlighted in POPular Study Comparing Platelet Reactivity Tests 6404 2Caliper Life Sciences Partners with Prestwick Chemical to Offer Customized Chemistry and Biology Programs for Drug Discovery Research 6400 1Caliper Life Sciences Partners with Prestwick Chemical to Offer Customized Chemistry and Biology Programs for Drug Discovery Research 6400 2Caliper Life Sciences Partners with Prestwick Chemical to Offer Customized Chemistry and Biology Programs for Drug Discovery Research 6400 3